Real Stories. Real Science. Real Time., The Hive hero

Meet the participants

Real Stories. Real Science. Real Time. Meet the companies selected to take part in The Hive - Elsevier's new program for startups that provides complimentary access to Elsevier’s suite of solutions to power their R&D. Follow The Hive to read their accounts of discovery and development fueled by access to the world’s top research solutions.

Read the Press Release

Arctic Pharma AS

Arctic Pharma AS - The Hive | Elsevier

Aiming to be a leader in environmentally friendly cancer therapies that have few side effects, Arctic Pharma AS is a start-up company developing innovative anti-cancer drugs by exploiting the sweet tooth of cancer cells. The company targets key enzymes that are upregulated in cancer cell metabolism using inhibitors designed by them. This enables them to develop new pharmaceuticals with fewer side effects to combat cancer.

Read more

Myelo Therapeutics

Myelo Therapeutics - The Hive | Elsevier

Myelo Therapeutics is a Germany-based pharmaceuticals company that develops innovative treatments in areas of high unmet medical needs.The company’s lead compound, Myelo001 – the first new therapy option for chemotherapy-induced neutropenia (CIN) in over 20 years – is currently being investigated in a clinical trial.

Read more

Reset Therapeutics

Reset Therapeutics - The Hive | Elsevier

Reset Therapeutics is a discovery-stage biopharma company developing first-in-class approaches to treating diseases by restoring the body’s natural 24-hour, or circadian, rhythms. Reset’s pipeline includes new chemical entities designed to treat Cushing’s disease, type-2 diabetes and other metabolic disorders and narcolepsy and other disorders associated with excessive daytime sleepiness.

Read more

Rubius Therapeutics

Rubius Therapeutics - The Hive | Elsevier

Rubius Therapeutics is using breakthrough science to develop a new class of drugs, Red-Cell Therapeutics™ (RCTs), with the potential to address many areas of human disease, including metabolic conditions, autoimmune disorders, cancer and infectious diseases. Using its rapid prototyping capability, the company has already generated more than 150 different RCT prototypes and is in the process of validating the most promising candidates for clinical entry.

Read more

Learn More About Elsevier R&D Solutions for
Early Stage Drug Discovery and Development:


Improve R&D productivity with a chemistry research solution that delivers experimental facts on chemical structures, properties, reactions and procedures.

Learn more

Reaxys Medicinal Chemistry

Empower hit identification and lead optimization with normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.

Learn more


Increase the discovery of biomedical evidence to support critical life sciences functions, with access to the world's most comprehensive biomedical literature database.

Learn more


Enable better informed preclinical drug safety decisions with comprehensive, fully searchable FDA/EMA drug approval documents and comparative extracted drug safety data.

Learn more


Reduce time spent monitoring, organizing and annotating scientific and medical literature for triage and compliance reports such as PSURs and ICSRs.

Learn more

Pathway Studio

Enable better understanding of biological processes underlying disease progression and treatment response, with a solution that helps researchers interpret experimental data from scientific literature.

Learn more

Professional Services

Drive pharmaceutical research towards innovative directions by working with Elsevier's Professional Services team to resolve challenges with data quality and integration.

Learn more

Text Mining

Get meaningful answers to complex pharma R&D research questions through Elsevier's custom Text Mining service that enables the retrieval of highly specified information from unstructured content.

Learn more


Enable researchers to more effectively and efficiently search authoritative, full­text scientific, technical and health content through the use of smart, intuitive functionality.

Learn more


Help researchers discover trends, partners and experts with the world’s largest abstract & citation database of peer­reviewed literature, including tools to track, analyze and visualize research.

Learn more